PD Research Studies


Check this link for the National Institutes of Health's current research studies across the country. 

These are some of the research studies that are looking for volunteers from the PD Community.  

1)  Dr. Mark LeDoux with Veracity Neuroscience (www.memphismovementdisorders.com) is site-principal investigator for a Pharma2B study (P2B001) of early PD.  P2B001 is a twelve-week, randomized, double-blind, double-dummy, 4-arm, parallel group, multi-center, multinational study to determine the efficacy, safety and tolerability of P2B001 in subjects with early PD as compared to its individual components and compared to a calibration arm of pramipexole ER (https://clinicaltrials.gov/ct2/show/NCT03329508).  A total of 525 early stage untreated PD patients will be randomized to 4-arms of treatment.  Subjects will be recruited from approximately 70 sites in North America and Europe.  Please contact Dr. LeDoux’s office at 901-443-9170 or support@veracityneuroscience.com if you are interested in participating.

2) Dr. Mark LeDoux with Veracity Neuroscience (www.memphismovementdisorders.com) is participating in the TOPAZ Trial (https://clinicaltrials.gov/ct2/show/NCT03924414). The TOPAZ study will test is a medicine called zoledronic acid can prevent fractures in people with PD. A team of doctors who are experts in bone health and PD are leading the study. Enrollment is via invitation only. Please contact Dr. LeDoux's office at 901-443-9170 or support@veracityneuroscience.com if you are interested in participating.